Showing posts with label teriflunomide. Show all posts
Showing posts with label teriflunomide. Show all posts

Tuesday 26 November 2013

Genzyme gets Health Canada approval for multiple sclerosis drug Aubagio



Genzyme gets Health Canada approval for multiple sclerosis drug Aubagio
Sanofi firm Genzyme has received approval from Health Canada for its once-daily drug Aubagio (teriflunomide) 14mg as monotherapy to treat patients with relapsing remitting multiple sclerosis (RRMS). 


read all here